|
||
Journal of Experimental Medicine, Vol 173, 779-782, Copyright © 1991 by Rockefeller University Press
ARTICLES |
Y Chvatchko and HR MacDonald
Ludwig Institute for Cancer Research, Lausanne Branch, Epalinges, Switzerland.
Recent studies indicate that both CD4+ and CD8+ T lymphocytes proliferate in vitro in response to Mls-1a-encoded determinants. Using both immunogenetic and antibody blocking approaches we show here that Mls-1a responses of both subsets require expression of major histocompatibility complex (MHC) class II molecules (I-A and/or I-E) by the stimulator cells. Furthermore, CD8+ T cell responses to Mls- 1a/class II MHC do not require (and are in fact inhibited by) the presence of functional CD8 molecules. Taken together, our data underscore the dramatic differences between CD8+ T cell responses to conventional peptide antigens as opposed to "superantigens" such as Mls- 1a.
| TABLE OF CONTENTS |
|